Segall Bryant & Hamill, LLC Geron Corp Transaction History
Segall Bryant & Hamill, LLC
- $7.16 Billion
- Q3 2024
A detailed history of Segall Bryant & Hamill, LLC transactions in Geron Corp stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 4,077,079 shares of GERN stock, worth $16.6 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
4,077,079
Previous 4,117,336
0.98%
Holding current value
$16.6 Million
Previous $17.5 Million
6.03%
% of portfolio
0.26%
Previous 0.31%
Shares
6 transactions
Others Institutions Holding GERN
# of Institutions
275Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$189 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$180 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$132 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$131 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$118 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.54B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...